111 related articles for article (PubMed ID: 37140994)
1. Hematopoietic progenitor kinase 1 inhibits the development and progression of pancreatic intraepithelial neoplasia.
Wang H; Moniruzzaman R; Li L; Ji B; Liu Y; Zuo X; Abbasgholizadeh R; Zhao J; Liu G; Wang R; Tang H; Sun R; Su X; Tan TH; Maitra A; Wang H
J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37140994
[TBL] [Abstract][Full Text] [Related]
2. Cytokine CCL9 Mediates Oncogenic KRAS-Induced Pancreatic Acinar-to-Ductal Metaplasia by Promoting Reactive Oxygen Species and Metalloproteinases.
Liou GY; Byrd CJ; Storz P; Messex JK
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731942
[TBL] [Abstract][Full Text] [Related]
3. Oral bacteria accelerate pancreatic cancer development in mice.
Saba E; Farhat M; Daoud A; Khashan A; Forkush E; Menahem NH; Makkawi H; Pandi K; Angabo S; Kawasaki H; Plaschkes I; Parnas O; Zamir G; Atlan K; Elkin M; Katz L; Nussbaum G
Gut; 2024 Apr; 73(5):770-786. PubMed ID: 38233197
[TBL] [Abstract][Full Text] [Related]
4. NEMO/NF-κB signaling functions as a double-edged sword in PanIN formation versus progression to pancreatic cancer.
Tsesmelis M; Büttner UFG; Gerstenlauer M; Manfras U; Tsesmelis K; Du Z; Sperb N; Weissinger SE; Möller P; Barth TFE; Maier HJ; Chan LK; Wirth T
Mol Cancer; 2024 May; 23(1):103. PubMed ID: 38755681
[TBL] [Abstract][Full Text] [Related]
5. Dichotomous role of the serine/threonine kinase MAP4K4 in pancreatic ductal adenocarcinoma onset and metastasis through control of AKT and ERK pathways.
Juin A; Spence HJ; Machesky LM
J Pathol; 2024 Apr; 262(4):454-466. PubMed ID: 38229581
[TBL] [Abstract][Full Text] [Related]
6. A neuroligin-2-YAP axis regulates progression of pancreatic intraepithelial neoplasia.
Middonti E; Astanina E; Vallariello E; Hoza RM; Metovic J; Spadi R; Cristiano C; Papotti M; Allavena P; Novelli F; Parab S; Cappello P; Scarpa A; Lawlor R; Di Maio M; Arese M; Bussolino F
EMBO Rep; 2024 Apr; 25(4):1886-1908. PubMed ID: 38413734
[TBL] [Abstract][Full Text] [Related]
7. ST6GAL1 sialyltransferase promotes acinar to ductal metaplasia and pancreatic cancer progression.
Bhalerao N; Chakraborty A; Marciel MP; Hwang J; Britain CM; Silva AD; Eltoum IE; Jones RB; Alexander KL; Smythies LE; Smith PD; Crossman DK; Crowley MR; Shin B; Harrington LE; Yan Z; Bethea MM; Hunter CS; Klug CA; Buchsbaum DJ; Bellis SL
JCI Insight; 2023 Oct; 8(19):. PubMed ID: 37643018
[TBL] [Abstract][Full Text] [Related]
8. Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation.
Zhang AMY; Xia YH; Lin JSH; Chu KH; Wang WCK; Ruiter TJJ; Yang JCC; Chen N; Chhuor J; Patil S; Cen HH; Rideout EJ; Richard VR; Schaeffer DF; Zahedi RP; Borchers CH; Johnson JD; Kopp JL
Cell Metab; 2023 Dec; 35(12):2119-2135.e5. PubMed ID: 37913768
[TBL] [Abstract][Full Text] [Related]
9. 3D genomic mapping reveals multifocality of human pancreatic precancers.
Braxton AM; Kiemen AL; Grahn MP; Forjaz A; Parksong J; Mahesh Babu J; Lai J; Zheng L; Niknafs N; Jiang L; Cheng H; Song Q; Reichel R; Graham S; Damanakis AI; Fischer CG; Mou S; Metz C; Granger J; Liu XD; Bachmann N; Zhu Y; Liu Y; Almagro-Pérez C; Jiang AC; Yoo J; Kim B; Du S; Foster E; Hsu JY; Rivera PA; Chu LC; Liu F; Fishman EK; Yuille A; Roberts NJ; Thompson ED; Scharpf RB; Cornish TC; Jiao Y; Karchin R; Hruban RH; Wu PH; Wirtz D; Wood LD
Nature; 2024 May; 629(8012):679-687. PubMed ID: 38693266
[TBL] [Abstract][Full Text] [Related]
10. Role of the fatty pancreatic infiltration in pancreatic oncogenesis.
Frendi S; Martineau C; Cazier H; Nicolle R; Chassac A; Albuquerque M; Raffenne J; Le Faouder J; Paradis V; Cros J; Couvelard A; Rebours V
Sci Rep; 2024 Mar; 14(1):6582. PubMed ID: 38503902
[TBL] [Abstract][Full Text] [Related]
11. Resolution of acinar dedifferentiation regulates tissue remodeling in pancreatic injury and cancer initiation.
Baldan J; Camacho-Roda J; Ballester M; Høj K; Kurilla A; Maurer HC; Arcila-Barrera S; Lin X; Pan Z; Leitão Castro J; Mayorca Guiliani AE; Rift CV; Hasselby J; Bouwens L; Lefebvre V; David CJ; Parnas O; DelGiorno KE; Erler J; Rooman I; Arnes L
Gastroenterology; 2024 May; ():. PubMed ID: 38729450
[TBL] [Abstract][Full Text] [Related]
12. Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress.
Chen H; Guan X; He C; Lu T; Lin X; Liao X
Expert Opin Ther Targets; 2024 Apr; 28(4):237-250. PubMed ID: 38650383
[TBL] [Abstract][Full Text] [Related]
13. Discovery of quinazoline HPK1 inhibitors with high cellular potency.
Toure M; Johnson T; Li B; Schmidt R; Ma H; Neagu C; Lopez AU; Wang Y; Guler S; Xiao Y; Henkes R; Ho K; Zhang S; Chu CL; Gundra UM; Porichis F; Li L; Maurer CK; Fang Z; Musil D; DiPoto M; Friis E; Jones R; Jones C; Cummings J; Chekler E; Tanzer EM; Huck B; Sherer B
Bioorg Med Chem; 2023 Sep; 92():117423. PubMed ID: 37531921
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 5-aminopyrido[2,3-d]pyrimidin-7(8H)-one derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitors.
Qiu X; Liu R; Ling H; Zhou Y; Ren X; Zhou F; Zhang J; Huang W; Wang Z; Ding K
Eur J Med Chem; 2024 Apr; 269():116310. PubMed ID: 38479166
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of 1H-pyrazolo[3,4-d]pyrimidine derivatives as hematopoietic progenitor kinase 1 (HPK1) inhibitors.
Zhang J; Li Y; Tang H; Zhou Q; Tong L; Ding J; Xie H; Xiong B; Liu T
Bioorg Chem; 2023 Nov; 140():106811. PubMed ID: 37659145
[TBL] [Abstract][Full Text] [Related]
16. Roles of differently polarized macrophages in the initiation and progressionof pancreatic cancer.
Storz P
Front Immunol; 2023; 14():1237711. PubMed ID: 37638028
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds.
Vara BA; Levi SM; Achab A; Candito DA; Fradera X; Lesburg CA; Kawamura S; Lacey BM; Lim J; Methot JL; Xu Z; Xu H; Smith DM; Piesvaux JA; Miller JR; Bittinger M; Ranganath SH; Bennett DJ; DiMauro EF; Pasternak A
ACS Med Chem Lett; 2021 Apr; 12(4):653-661. PubMed ID: 33859804
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of 2,4-diaminopyrimidine derivatives as potent Hematopoietic Progenitor Kinase 1 (HPK1) inhibitors.
Fu S; Wei J; Li C; Zhang N; Yue H; Yang A; Xu J; Dong K; Xing Y; Tong M; Shi X; Xi Z; Wang H; Hou Y; Zhao Y
Bioorg Chem; 2024 May; 148():107454. PubMed ID: 38795581
[TBL] [Abstract][Full Text] [Related]
19. Novel Diaminopyrimidine Carboxamides as HPK1 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Jul; 14(7):899-900. PubMed ID: 37465291
[TBL] [Abstract][Full Text] [Related]
20. Discovery of diaminotriazine carboxamides as potent inhibitors of hematopoetic progenitor kinase 1.
Zhou L; Ye X; Wang K; Shen H; Wang T; Zhang X; Jiang S; Xiao Y; Zhang K
Bioorg Chem; 2023 Sep; 138():106682. PubMed ID: 37339563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
